Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
243.80
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,248
Open
243.80
Bid (Size)
244.00 (200)
Ask (Size)
246.50 (300)
Prev. Close
243.80
Today's Range
243.80 - 243.80
52wk Range
190.75 - 267.47
Shares Outstanding
N/A
Dividend Yield
2.84%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
August 04, 2026
Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)
From
American News Group
Via
GlobeNewswire
AbbVie (ABBV) Q2 2026 Earnings Call Transcript
↗
August 03, 2026
Revenue beat guidance as immunology and neuroscience portfolios drive growth.
Via
The Motley Fool
Topics
Earnings
Economy
Performance
YTD
+6.3%
+6.3%
1 Month
-4.3%
-4.3%
3 Month
+18.3%
+18.3%
6 Month
+8.0%
+8.0%
1 Year
+23.6%
+23.6%
More News
Read More
The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
↗
August 03, 2026
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Stocks
AbbVie (NYSE:ABBV) Shares Slip on Apogee Acquisition Despite In-Line Q2 Results
↗
July 31, 2026
Via
Chartmill
Cannabis Theme's Hidden Strength: Established Players Outshining Pure Plays
↗
July 30, 2026
Via
Chartmill
Topics
Cannabis
AbbVie Quietly Solved Its Biggest Problem—Now What?
↗
August 02, 2026
Via
MarketBeat
Topics
Intellectual Property
ABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset
August 01, 2026
Via
StockStory
Why AbbVie Stock Slumped Today
↗
July 31, 2026
Via
The Motley Fool
Topics
Earnings
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
↗
July 31, 2026
Via
Benzinga
AbbVie Q2 Earnings Call Highlights
↗
July 31, 2026
Via
MarketBeat
Topics
ETFs
Earnings
AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat
↗
July 31, 2026
Via
Benzinga
AbbVie’s (NYSE:ABBV) Q2 CY2026: Beats On Revenue
July 31, 2026
Via
StockStory
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
↗
July 31, 2026
Via
Chartmill
What To Expect From AbbVie’s (ABBV) Q2 Earnings
July 29, 2026
Via
StockStory
Topics
Artificial Intelligence
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
↗
July 29, 2026
Via
The Motley Fool
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
↗
July 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should You Buy AbbVie Stock Hand Over Fist Before July 31?
↗
July 27, 2026
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?
↗
July 26, 2026
Via
The Motley Fool
Why Wall Street Can't Get Enough of This Dividend King
↗
July 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
↗
July 24, 2026
Via
The Motley Fool
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
July 23, 2026
From
Genmab A/S and AbbVie
Via
Business Wire
I'd Double a Position in These 3 Dividend Stocks Right Now Without Any Hesitation
↗
July 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow
↗
July 21, 2026
Via
The Motley Fool
Topics
Intellectual Property
PJP vs. IYH: Which Healthcare ETF Is the Better Buy?
↗
July 20, 2026
Via
The Motley Fool
Topics
ETFs
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?
↗
July 19, 2026
Via
The Motley Fool
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 243.80
When was AbbVie last traded?
The last trade of AbbVie was at 08/04/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today